European Archives - Page 1116 of 1158 - European Medical Journal

Predictive Value of MRI for Clinical Outcomes

The meeting outlined the evidence that the use of magnetic resonance imaging (MRI) markers as surrogate endpoints in clinical trials of…

EMJ Neurology 3 [Suppl 2] 2015

The meeting outlined the evidence that the use of magnetic resonance imaging (MRI) markers as surrogate endpoints in clinical trials of relapsing…

EMJ

Adjuvant chemotherapy use in breast cancer after introducing the Oncotype DX® Breast Cancer Assay

The Oncotype DX® Breast Cancer Assay, a multigene assay, stratifies breast cancer patients into groups that are at low, intermediate or high risk for…

EMJ

Type 1 Diabetes Stunts Brain Growth

CHILDREN with Type 1 diabetes (T1D) have shown slower brain growth than children without the disease. Frequent exposure to hyperglycaemia afflicting…

EMJ

Nature and Nurture Come Together to Trigger Diabetes

THE EPIGENOME has been revealed to play a significant role in diabetes onset, providing clues into how genes and the environment interact…

EMJ

AbbVie’s VIEKIRAX® (Ombitasvir/Paritaprevir/Ritonavir) and EXVIERA ® (Dasabuvir) Licensed for Use in the UK for the Treatment of Chronic Hepatitis C

MAIDENHEAD, UK, Jan. 19, 2015 – AbbVie’s all-oral, short course (12 weeks for the majority of patients), interferon-free treatments VIEKIRAX®…

EMJ

New Stats Reveal Almost Half of the UK Are Unaware of Crucial Link between Diet and Cancer Development

Surprising new statistics reveal that 41% of the British population are oblivious to the role that diet plays in the development of cancer…

EMJ

Targeting Monocytes to Help Treat Autoimmune Disorders?

SUPPRESSION of the immune system in fighting diseases could be the fault of a population of white blood cells (WBCs), a group of studies led by…

EMJ

Monitoring ADMA Levels the Key to Avoiding Cardiovascular Disease?

FEARFUL side-effects that have prohibited the appearance of certain anti-inflammatory arthritis drugs in our pharmacies could soon become irrelevant…

Editor’s Pick: Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?

Due to its increasing prevalence, exceeding 25% of the Western population, non-alcoholic fatty liver disease (NAFLD) merits recognition as one of the…